Information to help professionals prevent misuse, provide quality treatment and recovery services, and reduce death and harm.
- Naloxone FAQ
- NARCAN® Direct Program
- Standing Order for Naloxone
- Naloxone Administration in Outpatient Mental Health and Substance Use Disorder Clinics, P-02138 (PDF)
- Law Enforcement Guidelines: Intranasal NARCAN® (Naloxone) Administration, P-01787 (PDF)
- Pharmacy Society of Wisconsin
- Wisconsin Dental Association
- Wisconsin Medical Society
- Wisconsin Society of Addiction Medicine
- ED2Recovery Trainings
- Comprehensive Training for Dentists: Dental Pain Management in the Midst of the Evolving Substance Use Disorder Epidemic
- DHS Conferences/Trainings
- Opioid Forum
- Opioid Treatment and Recovery in the Emergency Department (6 part video series)
- Substance Use Treatment Project ECHO®
- Women's Treatment Project ECHO®
Alliance for Wisconsin Youth
The Alliance for Wisconsin Youth brings together local coalitions focused on substance use prevention.
2021 Opioids, Stimulants, and Trauma Summit
Sign up to receive notices about funding opportunities, reports and data, and events.
Addiction Technology Transfer Center
- Educational Package for Counselors and Psychologists
- Educational Package for Peer Support Workers
- Educational Package for Social Workers
Centers for Disease Control and Prevention
- Assessing Benefits and Harms of Opioid Therapy (PDF)
- Checklist for Prescribing Opioids for Chronic Pain (PDF)
- Evidence-Based Strategies for Preventing Opioid Overdose (PDF)
- Nonopioid Treatments for Chronic Pain (PDF)
- Opioid Guideline App
- Training for Providers
Office of National Drug Control Policy
Substance Abuse and Mental Health Services Administration
- A Collaborative Approach to the Treatment of Pregnant Women with Opioid Use Disorder (PDF)
- Clinical Guidance for Treating Pregnant and Parenting Women with Opioid use Disorder and Their Infants (PDF)
- Employee Assistance Program (EAP) Prescription Drug Toolkit and Fact Sheets (PDF)
- Focus on Prevention (PDF)
- Guidance for Law Enforcement and First Responders Administering Naloxone
- Keeping Youth Drug Free (PDF)
- Linking Older Adults with Medication, Alcohol, and Mental Health Resources (PDF)
- Opioid Overdose Prevention Toolkit (PDF)
- TIP 63: Medications for Opioid Use Disorder (PDF)
- Use of Medication-Assisted Treatment in Emergency Departments (PDF)
- Use of Medication-Assisted Treatment for Opioid Use Disorder in Criminal Justice Settings (PDF)
U.S. Surgeon General
- Advisory on Naloxone and Opioid Overdose
- Facing Addiction in America, The Surgeon’s General’s Spotlight on Opioids (PDF)
- Facts and recommendations for state, local, and tribal governments (PDF)
Get qualified to prescribe buprenorphine
Information from the Substance Abuse and Mental Health Services Administration on the waiver application and management process to prescribe or dispense buprenorphine for opioid dependency treatment.
HIPPA and the opioid crisis
Guidance from the U.S. Department of Health and Human Services Office for Civil Rights explains when HIPAA permits health care providers and other covered entities to share a patient’s health information with loved ones and others involved in a patient’s care.
- Providers can share information with an individual patient's loved ones in certain emergency or dangerous situations, such as when the patient is in a crisis and incapacitated, or is facing a serious and imminent threat of harm.
- Patients with decision-making capacity retain their right to decide when and whether their information will be shared, unless there is a serious and imminent threat of harm.
- Patients' personal representatives, who have authority under state law to make health care decisions for patients, may request and obtain information on behalf of patients.